NDC 55513-840

AIMOVIG

Erenumab-aooe

AIMOVIG is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Erenumab.

• Product ID: 55513-840_017de7ab-e700-44c1-a15d-8f1ad3fbb56f
• NDC: 55513-840
• Product Type: Human Prescription Drug
• Proprietary Name: AIMOVIG
• Generic Name: Erenumab-aooe
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2018-05-22
• Marketing Category: BLA / BLA
• Application Number: BLA761077
• Labeler Name: Amgen Inc
• Substance Name: ERENUMAB
• Active Ingredient Strength: 70 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 55513-840-01

1 SYRINGE, GLASS in 1 CARTON (55513-840-01) > 1 mL in 1 SYRINGE, GLASS

• Marketing Start Date: 2018-05-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 55513-840-01 [55513084001]

AIMOVIG INJECTION

• Marketing Category: BLA
• Application Number: BLA761077
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-05-22

NDC 55513-840-02 [55513084002]

AIMOVIG INJECTION

• Marketing Category: BLA
• Application Number: BLA761077
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-05-22
• Marketing End Date: 2021-01-31

Drug Details

Active Ingredients

Ingredient	Strength
ERENUMAB	70 mg/mL

OpenFDA Data

• SPL SET ID: b998ed05-94b0-47fd-b28f-cddd1e128fd8
• Manufacturer:
  • Amgen Inc
• UNII:
  • I5I8VB78VT
• RxNorm Concept Unique ID - RxCUI:
  • 2045627
  • 2120195
  • 2045636
  • 2056670
  • 2045638
  • 2120198
  • 2120199
  • 2056680
  • 2056681
  • 2045632
  • 2120193
  • 2056669
• UPC Code:
  • 0355513843010

NDC Crossover Matching brand name "AIMOVIG" or generic name "Erenumab-aooe"

NDC	Brand Name	Generic Name
55513-840	AIMOVIG	erenumab-aooe
55513-841	AIMOVIG	erenumab-aooe
55513-842	AIMOVIG	erenumab-aooe
55513-843	AIMOVIG	erenumab-aooe